11 Генетические основы иммунитета
.pdf81
(70%);
, N-
.
, -
.
.
1.4.3.2.2. I
I -
. ( 105 -
) .
I -
. , )
-
, ) -
( )
. I- -
. -
SD (Serologically Defined).
1.4.3.3. II
II
, ,
,
.
( , -
, , –
).
, .
« » -
« ». -
.
« » (rr) « » -
(Rr), « » (rr).
, -
, -
(Ir). -
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
82
Ir- .
1.4.3.3.1. II
II – Ia , -
, . . .
, . Ia- (
) ( , Ia-
). Ia
34000 28000 . -
, ( 1,2, 1 2), - -
( . 45). , Ia -
.
1.4.3.3.2. II
II ( . . 42
, , , -
Ir . ( . I region associated, Ia ).
II -
, I. ,
, -
.
II ( ) -
.
, , -
, . -
I II
. . -
, -
. -
-
. ( + -
) I ,
( ).
II , -
. , -
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
83
, -
– -
.
1980 . , -
,
( ), ( )
) .
,
. ,
14. 5: -1 ( 1- ), -2 ( 17- ), -3, -4 H- Y- . -
.
-2, -.
. ( )
-
. 2 .
-
.
-2 (Histocompatibility-2).
-2 -
.
-
.
( -2-
) 17-
(IX ). 0,35
, 5 ( , I, S, G, D) ( . 47).
(I, II III).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
84
. 47. -2 .
, -2 H-2D -
I ( ) .
I ) - II-
. I ( ) 5 ( -2 , -2 , -2J, -2E-2C). (Ir ), -
, Ia (I region associated
Immune associated). Ia .
S G (Ss Slp, ) -
III ( ) ( 4-
., .: [9 , . 77]).
, -2 , -
( ) . -
-
LD- ( .: Lymphocyte Defined).
-2 -
.
1.4.4.2.
HLA (Human Leucocyte Antigen), ,
. HLA
6 , -
1,6 . 5 , -
D, BF, B, C, A ( . 48).
, , , ,
I.
D, II.
, BF, III
).
, -
I 15- .
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
85
. 48. HLA- [6].
I HLA ( , -
, )
, – -
. -
(
) :
( ) > > -
> > > > > >
. -
HLA .
, . -
1 % .
7000 .
,
6-7
.
I II ( -2- )
(HLA- ) . , -
( ).
( 1, 2-, 3- 2-
I 1, 2, 1 2 II). -
1- 1 .
V- -
. 1-, 2- 2
.
-
.
3
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
86
|
|
- |
|
|
- |
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||
|
BoLA |
SLA |
OLA |
GLA |
ELA |
DLA |
|
|
I |
|
, , |
, |
SD1, |
|
, , |
B-F, |
|
|
|
|
|
SD2 |
|
|
B-G |
|
II |
D |
D |
– |
LD |
MLR |
D, E |
B-L |
|
III |
– |
+ |
– |
– |
– |
– |
+ |
|
- |
11 |
– |
16 |
– |
18 |
– |
– |
|
|
||||||||
|
|
|
|
|
|
|
||
Ir- |
+ |
+ |
– |
– |
– |
+ |
+ |
|
|
|
|
|
|
|
|
|
|
|
+ |
+ |
– |
– |
– |
– |
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
+ |
+ |
– |
– |
+ |
+ |
+ |
|
|
|
|
|
|
|
|
|
|
|
+ |
+ |
– |
– |
– |
+ |
– |
|
|
||||||||
|
|
|
|
|
|
|
||
- |
+ |
+ |
– |
– |
+ |
– |
+ |
|
|
||||||||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
- |
– |
+ |
– |
– |
– |
– |
+ |
|
|
||||||||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
1.4.4.3. -
HLA , -
:
– BoLA (Bovine leycocyte antigene) ;
– SLA (Sus scrofa leycocyte antigene) ;
–OLA (Ovine leycocyte antigene) ;
–GLA (Goat leycocyte antigene) ;
–ELA (Equine leycocyte antigene)
:
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
87
ChLA – , RhLA – , DLA – , GpLA –
, RLA – . – RT1. -
, –
.
. 49.
. [9 ].
, I , -
II -
, -
( . 49).
1.4.4.3.1.
BoLA I (SD) II (LD) . I 17 (W1-10 . .), -II – 11 . Ia , II -
Ir . , BoLA
. 0,04.
1.4.4.3.2.
SLA
7- ( .
. 50).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
88
. 50. SLA.
( , , ) I-
. , I 7- -
1.2-ql.2 ,
, , -2 H-2D
. (D) , -
II
. (Ir) -
. -
SLA. ,
d 0,92, – 0,11.
1.4.4.3.3.
OLA : , ,. 0,6 %.
16 OLA: OLA-A1, 2, 4, 8, 10, 13; OLA-B3,6, 7, 9, 12; OLA-C14, 15, 17; 8L 16L -
.
26 OLA.
OLA, (OL-X OL), -
.
1.4.4.3.4.
ELA 2
, I II.
, ELA W1-W10 Lex8 .
.
W5 Lex8
W2 W3.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
89
1.4.4.3.5.
( )
BG, BF, BL, .
BG BF/BL
(1/2000). BF BL . BF
, -
. BL ,
Ia . Ir -
, , , -
. BG
.
-
, ,
. , ,
, -
. -
.
, , Ir , -
,
.
HLA.
;
. 4.
-
.
–
:
+ : –)
. = + : –)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .
90
-
:
|
|
|
|
|
|
(+) |
(–) |
(+) |
|
a |
b |
(–) |
|
c |
d |
|
. = a·d / b·c |
|
, -
HLA-B8 [9 , .66].
|
|
|
HLA-B8 |
|
|
|
(+) |
|
(–) |
(+) |
|
17 |
|
12 |
(–) |
|
189 |
|
811 |
|
. = 17 |
·811 / 12·189 = |
6,1 |
,
.
, .
.
, -, .
. 4,
HLA -
, .
-
( ) HLA B27. -
– -
, ( -
) . HLA B27
. B27 93%
,
8% .
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––---------------
. . 7. . .
: , 2006. – 142 .